Ruby Dhar
Overview
Explore the profile of Ruby Dhar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
447
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Singh S, Goel I, Quadri J, Minocha R, Kashyap N, Rana A, et al.
J Physiol
. 2025 Feb;
603(5):1263-1279.
PMID: 39985149
Sulphur dioxide (SO₂) is a toxic air pollutant with deleterious effects on the respiratory, cardiovascular, endocrine and reproductive systems. SO₂, being freely diffusible, can cross the placenta and reach the...
2.
Srivastava T, Dhar R, Karmakar S
Reprod Biol Endocrinol
. 2025 Jan;
23(1):9.
PMID: 39833837
Breast cancer (BrCa) is a complex and heterogeneous disease with diverse molecular subtypes, leading to varied clinical outcomes and posing significant treatment challenges. The increasing global burden of BrCa, particularly...
3.
Sahoo O, Sapam D, Ajmeria S, Aidasani H, Dhar R, Karmakar S
Rev Med Virol
. 2025 Jan;
35(1):e70015.
PMID: 39832826
Purpose: As humanity grapples with the COVID-19 pandemic caused by the novel SARS-CoV-2 virus, the rising threats of the MPox virus (MPXV) in 2022 and 2024 have shown signs of...
4.
Ajmeriya S, Kashyap N, Gul A, Ahirwar A, Singh S, Tripathi S, et al.
Placenta
. 2024 Nov;
159():9-19.
PMID: 39602836
Introduction: Solute carrier family transporters (SLCs), crucial for nutrient and trace element uptake in the placenta, play a significant role in fetal growth and development. Their dysregulation is associated with...
5.
Srivastava T, Ajmeriya S, Goel I, Talukdar J, Srivastava A, Parshad R, et al.
BMC Cancer
. 2024 Nov;
24(1):1398.
PMID: 39538154
Background: The Androgen Receptor (AR) has emerged as an endocrine therapy target in Breast Cancer, exhibiting up to 80% expression in clinical cases. AR-V7, a constitutively activated splice variant of...
6.
Singh S, Goel I, Tripathi S, Ahirwar A, Kumar M, Rana A, et al.
Environ Sci Pollut Res Int
. 2024 Oct;
31(50):59819-59851.
PMID: 39388084
Air pollution has become a major health concern, particularly for vulnerable populations such as the elderly, children, and pregnant women. Studies have reported a strong association between prenatal exposure to...
7.
William J, Dhar R, Gundamaraju R, Sahoo O, Pethusamy K, Raj A, et al.
Front Oncol
. 2024 Apr;
14:1288501.
PMID: 38559562
SKP2 (S-phase kinase-associated protein 2) is a member of the F-box family of substrate-recognition subunits in the SCF ubiquitin-protein ligase complexes. It is associated with ubiquitin-mediated degradation in the mammalian...
8.
Sarkar S, Srivastava T, Sahoo O, Shankar A, Rai A, Pethusamy K, et al.
Asian Pac J Cancer Prev
. 2024 Mar;
25(3):747-756.
PMID: 38546057
QDs are semiconductor nanocrystalline materials with distinct optical and electronic characteristics due to their microscopic size and quantum mechanical properties. They are often composed of materials such as cadmium selenide...
9.
Seethy A, Pethusamy K, Kushwaha T, Kumar G, Talukdar J, Chaubey R, et al.
BMC Cancer
. 2023 Oct;
23(1):1035.
PMID: 37884893
Background: Myelodysplastic Neoplasms (MDS) are clonal stem cell disorders characterized by ineffective hematopoiesis and progression to acute myeloid leukemia, myelodysplasia-related (AML-MR). A major mechanism of pathogenesis of MDS is the...
10.
Purkayastha K, Dhar R, Pethusamy K, Srivastava T, Shankar A, Rath G, et al.
J Cancer Res Ther
. 2023 May;
19(Supplement):S20-S35.
PMID: 37147979
A biomarker is a measurable indicator used to distinguish precisely/objectively either normal biological state/pathological condition/response to a specific therapeutic intervention. The use of novel molecular biomarkers within evidence-based medicine may...